Therapeutic potential of oxazole scaffold: a patent review (2006–2017)

References

• Haider S. Heterocycles, back bone of drug design. J Phytochemistry Biochem. 2017;1:1.
   Google Scholar
• Eftekhari-Sis B, Zirak M, Akbari A. Arylglyoxals in synthesis of heterocyclic compounds. Chem Rev. 2013;113:2958–3043.
   PubMed Web of Science ®Google Scholar
• Ansari A, Ali A, Asif A, et al. Review: biologically active pyrazole derivatives. New J Chem. 2017;41:16–41.
   Web of Science ®Google Scholar
• Al-Mulla A. A review: biological importance of heterocyclic compounds. Der Pharma Chem.. 2017;9:141–147.
   Google Scholar
• Bansal RK. Heterocyclic chemistry. New Delhi: New Age International Publishers; 2017.
   Google Scholar
• Gilchrist TL. Heterocyclic chemistry. England: Pearson; 1997.
   Google Scholar
• Turchi IJ, Dewar MJS. Chemistry of oxazoles. Chem Rev. 1975;75:389–437.
   Web of Science ®Google Scholar
• Karimoto RS, Axelrod B, Wolinsky J, et al. The structure and synthesis of annuloline, an oxazole alkaloid occurring in annual rye grass. Phytochemistry. 1964;3:349–355.
   Web of Science ®Google Scholar
• Cornforth JW, Cornforth RH. A new synthesis of oxazoles and iminazoles including its application to the preparation of oxazole. J Chem Soc. 1947;0:96–102.
   Web of Science ®Google Scholar
• Bredereck H, Gompper, R, Hayer D. Imidazole synthesis with formamide. Chem Ber. 1953;86:88–96.
   Google Scholar
• Bredereck H, Bangert R. Synthesis of oxazole. Angew Chem Int Ed Engl. 1962;12:662–663.
   Google Scholar
• Wasserman HH, Vinick FJ. Mechanism of the Robinson-Gabriel synthesis of oxazoles. J Org Chem. 1973;38:2407–2408.
   Web of Science ®Google Scholar
• Schill G, Sosnovsky G, Ziegler H.J. Reactiones Organicae. Synthesis. 1972;3:148.
   Google Scholar
• Van Leusen AM, Hoogenboom BE, Siderius H. A novel and efficient synthesis of oxazoles from tosylmethylisocyanide and carbonyl compounds. Tetrahedron Lett. 1972;23:2369–2372.
   Google Scholar
• Joshi S, Bisht AS, Juyal D. Systematic scientific study of 1, 3-oxazole derivatives as a useful lead for pharmaceuticals: a review. Pharma Innov. 2017;6:109–117.
   Google Scholar
• Peng XM, Cai GX, Zhou CH. Recent developments in azole compounds as antibacterial and antifungal agents. Curr Top Med Chem. 2013;13:1963–2010.
   PubMed Web of Science ®Google Scholar
• Zhang H-Z, Zhao Z-L, Zhou C-H. Recent advance in oxazole-based medicinal chemistry. Eur J Med Chem. 2018;144:444–492.
   PubMed Web of Science ®Google Scholar
• Knowles RR, Carpenter J, Blakey SB, et al. Total synthesis of diazonamide A. Chem Sci. 2011;2:308–311.
   Web of Science ®Google Scholar
• Glockner S, Tran DS, Ingham RJ, et al. The rapid synthesis of oxazolines and their heterogeneous oxidation to oxazoles under flow conditions. Org Biomol Chem. 2015;13:207–214.
   PubMed Web of Science ®Google Scholar
• Chandrasekhar S, Sudhakar A. Total synthesis of bengazole A. Org Lett. 2010;12:236–238.
   PubMed Web of Science ®Google Scholar
• Yokokawa F, Asano T, Shioiri T. Total synthesis of the antiviral marine natural product (−)-hennoxazole A. Org Lett. 2000;2:4169–4172.
   PubMed Web of Science ®Google Scholar
• Balasubramanian M. Oxazoles and benzoxazoles. In: Li JJ, Gribble GW, editors. Palladium in heterocyclic chemistry: a guide for the synthetic chemist. New York: Elsevier; 2007. p. 380–383.
   Google Scholar
• Qiu G, Li Y, Wu J. Recent developments for the photoinduced Ar-X bond dissociation reaction. Org Chem Front. 2016;3:1011–1027.
   Web of Science ®Google Scholar
• Nishida A, Fuwa M, Fujikawa Y, et al. First total synthesis of martefragin A, a potent inhibitor of lipid peroxidation isolated from sea alga. Tetrahedron Lett. 1998;39:5983–5986.
   Web of Science ®Google Scholar
• Webb MR, Addie MS, Crawforth CM, et al. The syntheses of rac-inthomycin A, (+)-inthomycin B and (+)-inthomycin C using a unified synthetic approach. Tetrahedron. 2008;64:4778–4791.
   Web of Science ®Google Scholar
• Lin -C-C, Tantisantisom W, McAlpine SR. Total synthesis and biological activity of natural product urukthapelstatin A. Org Lett. 2013;15:3574–3577.
   PubMed Web of Science ®Google Scholar
• Matsuo Y, Kanoh K, Yamori T, et al. Urukthapelstatin A, a novel cytotoxic substance from marine-derived mechercharimyces asporophorigenens YM11-542. I. Fermentation, isolation and biological activities. J Antibiot (Tokyo). 2007;60:251–255.
   PubMed Web of Science ®Google Scholar
• Lazo JS, Reese CE, Vogt A, et al. Identifying a resistance determinant for the antimitotic natural products disorazole C1 and A1. J Pharmacol Exp Ther. 2010;332:906–911.
   PubMed Web of Science ®Google Scholar
• Fallona MC, McMorris TC, De Mayo P, et al. Griseoviridin. J Am Chem Soc. 1962;84:4162–4163.
   Web of Science ®Google Scholar
• Ahmed F, Donaldson W. Chemistry and biology of streptogramin A antibiotics. Mini Rev Org Chem. 2007;4:159–181.
   Web of Science ®Google Scholar
• Shin Y, Kim GD, Jeon J, et al. Antimetastatic effect of halichondramide, a trisoxazole macrolide from the marine sponge chondrosia corticata, on human prostate cancer cells via modulation of epithelial-to-mesenchymal transition. Mar Drugs. 2013;11:2472–2485.
   PubMed Web of Science ®Google Scholar
• https://www.drugbank.ca/drugs/DB00991[Last accessed 2018 Mar 05
   Google Scholar
• Qian J, Chen H, Birnbaum Y, et al. Aleglitazar, a balanced dual pparalpha and -gamma agonist, protects the heart against ischemia-reperfusion injury. cardiovasc drugs ther. 2016;30:129–141.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Rodney GG, Schneider MF. Effects of azumolene on Ca2+ sparks in skeletal muscle fibers. J Pharmacol Exp Ther. 2005;314:94–102.
   PubMed Web of Science ®Google Scholar
• Jain J, Almquist SJ, Shlyakhtar D, et al. VX-497: a novel, selective IMPDH inhibitor and immunosuppressive agent. J Pharm Sci. 2001;90:625–637.
   PubMed Web of Science ®Google Scholar
• Self CR, Barber WE, Machin PJ, et al. Romazarit: a potential disease-modifying antirheumatic drug. J Med Chem. 1991;34:772–777.
   PubMed Web of Science ®Google Scholar
• Zhang HZ, Gan LL, Wang H, et al. New progress in azole compounds as antimicrobial agents. Min Rev Med Chem. 2017;17:122–166.
   PubMed Web of Science ®Google Scholar
• Zhang L, Peng XM, Damu GL, et al. Comprehensive review in current developments of imidazole-based medicinal chemistry. Med Res Rev. 2014;34:340–437.
   PubMed Web of Science ®Google Scholar
• Zhou CH, Wang Y. Recent researches in triazole compounds as medicinal drugs. Curr Med Chem. 2012;19:239–280.
   PubMed Web of Science ®Google Scholar
• Li YS, Hu DK, Zhao DS, et al. Design, synthesis and biological evaluation of 2,4-disubstituted oxazole derivatives as potential PDE4 inhibitors. Bioorg Med Chem. 2017;25:1852–1859.
   PubMedGoogle Scholar
• Sadek B, Fahelelbom KM. Synthesis, characterization, and antimicrobial evaluation of oxadiazole congeners. Molecules. 2011;16:4339–4347.
   PubMed Web of Science ®Google Scholar
• Demmer CS, Bunch L. Benzoxazoles and oxazolopyridines in medicinal chemistry studies. Eur J Med Chem. 2015;97:778–785.
   PubMed Web of Science ®Google Scholar
• Sysak A, Obmińska-Mrukowicz B. Isoxazole ring as a useful scaffold in a search for new therapeutic agents. Eur J Med Chem. 2017;137:292–309.
   PubMed Web of Science ®Google Scholar
• Blumberg LC, Munchhof MJ Novel triazole and oxazole compounds as transforming growth factor (TGF) inhibitors. OA012927A (2006)
   Google Scholar
• Sutton JC, Wiesmann M, Wang W, et al. 6-O-Substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling. WO2007121484A2 (2007)
   Google Scholar
• Johann L, Harald S, Kristina W, et al. Novel heterocyclic NF-κB inhibitors. NZ565470A (2010)
   Google Scholar
• Rebek J Jr, Moisan L, Oxazole-pyridazine-oxazole apha-helix mimetic. US20100113466A1 (2010)
   Google Scholar
• Brown M, Johnson M Oxazole compounds compositions and methods of use. US20110060011A1 (2011)
   Google Scholar
• Feng Y, Lograsso P, Schroeter T, et al. Benzo[d]oxazoles and benzo[d]thiazoles as kinase inhibitors. WO2010024903A1 (2010)
   Google Scholar
• Adjabeng G, Bifuclo N, Davis-Ward RG, et al. Thiazole and oxazole kinase inhibitors. US20110098296A1 (2011)
   Google Scholar
• Adjabeng G, Baum E, Bifulco N, et al. Thaizole sulfonamide and oxazole sulfonamide kinase inhibitors. US20110319392A1 (2011)
   Google Scholar
• Adamas JL, Faitg T, Kasparec J, et al. Benzene sulphonamide thiazole and oxazole compounds. WO2011059610A1 (2011)
   Google Scholar
• Turkson J, Sebti S, Jove R, et al. STAT3 inhibitor having anticancer activity and methods. US20110124602A1 (2011)
   Google Scholar
• Ahmed K, Shetti RV, Reddy KS, et al. Pyrrolo[2,L-C][L,4] benzodiazepine-benzothiazole or benzoxazole conjugates linked through piperazine moiety and process for the preparation thereof. US20120316335A1 (2012)
   Google Scholar
• Diamond MI, Jones JO, Renslo AR Small-molecule inhibitors of the androgen receptor. US20130096095A1 (2013)
   Google Scholar
• Ren P, Liu Y, Li L, et al. Heterocyclic compounds and uses thereof. US20130261102A1 (2013)
   Google Scholar
• Pfahl M, Piedrafita FJ, Venkat LRC, et al. Novel substituted biarylheterocycle derivatives as protein kinase inhibitors for the treatment of cancer and other diseases. WO2013016720A2 (2013)
   Google Scholar
• Desai LS, Chittaboina S Aminooxazole inhibitors of cyclin dependent kinases. US20140051694A1 (2014)
   Google Scholar
• Reader JC, Ellard JM, Boffey H, et al. Oxazole tyrosine kinase inhibitors. US20150057282A1 (2015)
   Google Scholar
• Stefanski T, Rozanski J, Mikstacka R, et al. The new derivatives of (Z)-1,2-diphenylethene. US20150065727A1 (2015)
   Google Scholar
• Song JY, Ahn JY, Jung IS, et al. Anticancer supplement agent including benzo[d]oxazol derivative as effective ingredient. US20150197498A1 (2015)
   Google Scholar
• Dasgupta R, Rajulu GG, Dickson JK Novel oxazole compounds as β-catenin modulators and uses thereof. WO2016081451A1 (2016)
   Google Scholar
• Dasgupta R, Gonsalves F Oxazole and thiazole compounds as beta-catenin modulators and uses thereof. US20170049751A1 (2017)
   Google Scholar
• Puelles S, Sancho S Derivatives of 2-phenyl-7,7a-dihydro-3Ah-pyrano[3,4-d]oxazole-6(4H)-one. WO2016091789A1 (2016)
   Google Scholar
• Wolff, Bregman, Goller. Oxazole and thiazole derivatives and pharmaceutical compositions containing the same. IL147939B (2008)
   Google Scholar
• Luzzatto. Substituted oxazole and thiazole derivatives pharmaceutical compositions comprising the same and their use for the manufacture of medicaments for the treatment of hPPAR alpha disease or condition. IL149582B (2008)
   Google Scholar
• Birch AM, Davies R, Whalley DP Oxazole derivatives and their use in the treatment of diabetes and obesity. US20100160397A1 (2010)
   Google Scholar
• Luzzatto. Oxazolo/Thiazolo-pyridine derivatives and benzo-oxazole/thiazole derivatives, process for their preparation and pharmaceutical compositions comprising the same. IL189664B (2011)
   Google Scholar
• Grauert M, Bakker R, Breitfelder S, et al. Pyridazinones as GPR119 agonists. US20130172323A1 (2013)
   Google Scholar
• Rongze K, David B, Neng-Yang S, et al. Substituted 2-quinolyl-oxazoles useful as PDE4 inhibitors. NZ551017 (2010)
   Google Scholar
• Chobanian H, Lin LS, Liu P, et al. Oxazole derivatives useful as inhibitors of FAAH. US20110021531A1 (2011)
   Google Scholar
• Choo HYP, Kim YK, Choi JH, et al. Benzoxazole derivatives having inhibitory activity against Interleukin-6, preparation method thereof, and pharmaceutical composition containing the same. US20130090480A1 (2013)
   Google Scholar
• Martos JL, Carling WR, Woodward DF, et al. Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response. US20160068520A1 (2016)
   Google Scholar
• Frank-Foltyn R, Habermann C, Bahrenberg G, et al. Substituted oxazole- and thiazole-based carboxamide and urea derivatives as vanilloid receptor ligands II. WO2016082930A9 (2016)
   Google Scholar
• Corminboeuf O, Cren S, Pozzi D Difluoroethyl-oxazole substituted bridged spiro[2,4]Heptane derivatives as ALX receptor agonists. US20160289221A1 (2016)
   Google Scholar
• gChen L, Dillon MP, Feng L, et al. Thiazole and oxazole-substituted arylamides as P2X3 and P2X2/3 antagonists. US20170182057A1 (2017)
   Google Scholar
• Le Poul E, Palombi G, Rocher JP Oxazole derivatives as positive allosteric modulators of metabotropic glutamate receptors. US20100081690A1 (2010)
   Google Scholar
• Conn PJ, Lindsley CW, Stauffer SR, et al. Bicyclic oxazole lactams as allosteric modulators of MGLUR5 receptors. US20130252943A1 (2013)
   Google Scholar
• Conn PJ, Lindsley CW, Stauffer SR, et al. Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of MGLUR5 receptors. US20130261107A1 (2013)
   Google Scholar
• Boger DL Substituted oxazole ketone modulators of fatty acid amide hydrolase. US20100075931A1 (2010)
   Google Scholar
• Boger DL. C-4 substituted alpha-keto oxazoles. US20120302607A1 (2012)
   Google Scholar
• Boger DL Tricyclic inhibitors of Fatty acid amide hydrolase. US20100216750A1; (2010)
   Google Scholar
• Gijsen HJM, Bischoff FP, Zhuang W, et al. Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as Gamma Secretase modulators. WO2010094647A1 (2010)
   Google Scholar
• Chabrier De Lassauniere PE, Harnett J, Bigg D et al. Derivatives of heterocycles with 5 members, their preparation and their use as medicaments. US 20110172434A1 (2011)
   Google Scholar
• Krause KH, Preynat-Seauve O Methods and compositions related to dopaminergic neuronal cells. US20130149717A1 (2013)
   Google Scholar
• Munakata R, Inoue M, Tominaga H, et al. Chromane compounds. US20150225386A1 (2015)
   Google Scholar
• Liverton N, Bishore DC, Kuduk SD, et al. Oxazole orexin receptor antagonists. US 2016176858A1 (2016)
   Google Scholar
• Kuduk SD, Liverton N, Luo Y Oxazole orexin receptor antagonists. WO2016069515A1 (2016)
   Google Scholar
• Kuduk SD, Liverton N, Luo Y Methyl oxazole orexin receptor antagonists. WO 2016089721A1 (2016)
   Google Scholar
• Kuduk SD, Liverton N, Reger TS, et al. 5,5-Bicyclic oxazole orexin receptor antagonists. WO2016100162A2 (2016)
   Google Scholar
• Pevarello P, Lohmer S, Liberati C, et al. Substituted thiazole or oxazole P2X7 receptor antagonists. US20170008883A1 (2017)
   Google Scholar
• Ivachtchenko AV, Mitkin OD, Kadieva MG Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof. EP3072882A1 (2016)
   Google Scholar
• Wolff, Bregman, Goller. Fused imidazole and oxazole derivatives and pharmaceutical compositions containing the same as anti-bacterial agents. IL156031B (2011)
   Google Scholar
• Nan F, Zuo J, Wang W, et al. 2-Thiophen-2-yl-oxazole, 2-thiophen-2-yl-thiazole and 2-thiophen-2-yl-1H-imidazole derivatives as antiviral agents and the use thereof. SG172716A1 (2011)
   Google Scholar
• Fatheree PR, Hudson R, McKinnell RM Dual-acting oxazole antihypertensive agents. US20140194426A1 (2014)
   Google Scholar
• Wulff H, Coleman N, Brown BM, et al. Selective activators of the intermediate conductance CA2+ activated K+ channel KCA3.1 and their methods of use. US20170056376A1 (2017)
   Google Scholar
• Tinsley JM Pharmaceutical composition for the treatment of Duchenne muscular dystrophy. US20150238467A1 (2015)
   Google Scholar
• Moussy A, Benjahad A, Pez D, et al. Novel oxazole derivatives that inhibit SYK. WO2017046302A1 (2017)
   Google Scholar